- Home
- VOR vs OSUR Comparison
VOR vs OSUR Comparison
Compare VOR & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- OSUR
- Stock Information
- Founded
- VOR 2015
- OSUR 2000
- Country
- VOR United States
- OSUR United States
- Employees
- VOR N/A
- OSUR N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- OSUR Medical/Dental Instruments
- Sector
- VOR Health Care
- OSUR Health Care
- Exchange
- VOR Nasdaq
- OSUR Nasdaq
- Market Cap
- VOR 207.1M
- OSUR 231.1M
- IPO Year
- VOR 2021
- OSUR 1986
- Fundamental
- Price
- VOR $29.40
- OSUR $3.05
- Analyst Decision
- VOR Buy
- OSUR Hold
- Analyst Count
- VOR 6
- OSUR 1
- Target Price
- VOR $85.33
- OSUR $3.00
- AVG Volume (30 Days)
- VOR 526.1K
- OSUR 472.9K
- Earning Date
- VOR 11-06-2025
- OSUR 11-05-2025
- Dividend Yield
- VOR N/A
- OSUR N/A
- EPS Growth
- VOR N/A
- OSUR N/A
- EPS
- VOR N/A
- OSUR N/A
- Revenue
- VOR N/A
- OSUR $138,533,000.00
- Revenue This Year
- VOR N/A
- OSUR N/A
- Revenue Next Year
- VOR N/A
- OSUR $4.32
- P/E Ratio
- VOR N/A
- OSUR N/A
- Revenue Growth
- VOR N/A
- OSUR N/A
- 52 Week Low
- VOR $2.62
- OSUR $2.36
- 52 Week High
- VOR $65.80
- OSUR $4.60
- Technical
- Relative Strength Index (RSI)
- VOR 52.41
- OSUR 45.04
- Support Level
- VOR $28.65
- OSUR $2.94
- Resistance Level
- VOR $31.31
- OSUR $3.14
- Average True Range (ATR)
- VOR 3.26
- OSUR 0.11
- MACD
- VOR -1.89
- OSUR -0.02
- Stochastic Oscillator
- VOR 2.79
- OSUR 31.43
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.